{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T13:57:31Z","timestamp":1783432651576,"version":"3.54.6"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.medcli.2024.05.001","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T17:23:38Z","timestamp":1724174618000},"page":"S14-S21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"S1","title":["Obstetric antiphospholipid syndrome"],"prefix":"10.1016","volume":"163","author":[{"given":"Adriana","family":"Soto-Peleteiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Gonzalez-Echavarri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Ruiz-Irastorza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2024.05.001_bib0205","doi-asserted-by":"crossref","first-page":"18005","DOI":"10.1038\/nrdp.2018.5","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.medcli.2024.05.001_bib0210","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis","volume":"18","author":"Devreese","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.medcli.2024.05.001_bib0215","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.42624","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"75","author":"Barbhaiya","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.medcli.2024.05.001_bib0220","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.medcli.2024.05.001_bib0225","doi-asserted-by":"crossref","first-page":"e069717","DOI":"10.1136\/bmj-2021-069717","article-title":"Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management","volume":"380","author":"Knight","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.medcli.2024.05.001_bib0230","doi-asserted-by":"crossref","first-page":"e059519","DOI":"10.1136\/bmjopen-2021-059519","article-title":"Thrombophilia screening in women with recurrent first trimester miscarriage: is it time to stop testing? A cohort study and systematic review of the literature","volume":"12","author":"Shehata","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.medcli.2024.05.001_bib0235","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/aogs.13665","article-title":"The association between antiphospholipid antibodies and late fetal loss: a systematic review and meta-analysis","volume":"98","author":"Xu","year":"2019","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.medcli.2024.05.001_bib0240","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/rheumatology\/keaa203","article-title":"EUREKA algorithm predicts obstetric risk and response to treatment in women with different subsets of anti-phospholipid antibodies","volume":"60","author":"Pregnolato","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.medcli.2024.05.001_bib0245","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(15)00070-7","article-title":"Pre-eclampsia","volume":"387","author":"Mol","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2024.05.001_bib0250","doi-asserted-by":"crossref","unstructured":"ACOG Practice Bulletin No. 202. Gestational hypertension and preeclampsia. Obstet Gynecol 2019;133:e1\u2013e25.","DOI":"10.1097\/AOG.0000000000003020"},{"key":"10.1016\/j.medcli.2024.05.001_bib0255","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2024.05.001_bib0260","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American College of Rheumatology Guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.medcli.2024.05.001_bib0265","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2024.05.001_bib0270","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.reuma.2019.09.003","article-title":"Control del embarazo en pacientes con lupus eritematoso sist\u00e9mico\/s\u00edndrome antifosfol\u00edpido. Parte 2: Seguimiento del embarazo","volume":"17","author":"Rodr\u00edguez Almaraz","year":"2021","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.medcli.2024.05.001_bib0275","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/0961203315578765","article-title":"Primary prophylaxis to prevent obstetric complications in asymptomatic women with antiphospholipid antibodies: a systematic review","volume":"24","author":"Amengual","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.medcli.2024.05.001_bib0280","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.medcli.2024.05.001_bib0285","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1034\/j.1600-0897.2001.d01-13.x","article-title":"Risk factors associated with fetal loss in treated antiphospholipid syndrome pregnancies: a multivariate analysis","volume":"46","author":"Carmona","year":"2001","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.medcli.2024.05.001_bib0290","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ejogrb.2015.12.011","article-title":"Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT","volume":"197","author":"Van Hoorn","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.medcli.2024.05.001_bib0295","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0049-0172(99)80029-8","article-title":"Clinical study and follow-up of 100 patients with the antiphospholipid syndrome","volume":"29","author":"Mu\u00f1oz-Rodriguez","year":"1999","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.medcli.2024.05.001_bib0300","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.medcli.2024.05.001_bib0305","first-page":"131","article-title":"A study of sixty pregnancies in patients with the antiphospholipid syndrome","volume":"14","author":"Lima","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.medcli.2024.05.001_bib0310","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.mefs.2013.12.004","article-title":"Enoxaparin and aspirin therapy for recurrent pregnancy loss due to anti-phospholipid syndrome (APS)","volume":"19","author":"Mohamed","year":"2014","journal-title":"Middle East Fertil Soc J"},{"key":"10.1016\/j.medcli.2024.05.001_bib0315","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1093\/humrep\/17.11.2981","article-title":"Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population","volume":"17","author":"Franklin","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.medcli.2024.05.001_bib0320","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA trial","volume":"36","author":"Laskin","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.medcli.2024.05.001_bib0325","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/AOG.0b013e3181deba40","article-title":"Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis","volume":"115","author":"Ziakas","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.medcli.2024.05.001_bib0330","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/rheumatology\/kep373","article-title":"Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regression","volume":"49","author":"Mak","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.medcli.2024.05.001_bib0335","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1136\/annrheumdis-2015-208840","article-title":"The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation","volume":"75","author":"G\u00f6testam Skorpen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2024.05.001_bib0340","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.autrev.2015.01.012","article-title":"The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: data from a European multicenter retrospective study","volume":"14","author":"Mekinian","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.medcli.2024.05.001_bib0345","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1182\/blood-2011-02-339234","article-title":"First-trimester low-dose prednisolone in refractory antiphospholipid antibody-related pregnancy loss","volume":"117","author":"Bramham","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2024.05.001_bib0350","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3899\/jrheum.140737","article-title":"Prevalence and significance of persistently positive antiphospholipid antibodies in women with preeclampsia","volume":"42","author":"Gonzalez-Echavarri","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.medcli.2024.05.001_bib0355","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.reuma.2019.09.002","volume":"17","author":"Espinosa","year":"2021","journal-title":"Reumatol Clin"},{"key":"10.1016\/j.medcli.2024.05.001_bib0360","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/s-0042-1760255","article-title":"Venous thromboembolism associated with assisted reproductive technology: a systematic review and meta-analysis","volume":"123","author":"Goualou","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.medcli.2024.05.001_bib0365","unstructured":"Royal College of Obstetricians and Gynaecologists. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. Green Top Guideline n\u00b0 37a; April 2015."},{"key":"10.1016\/j.medcli.2024.05.001_bib0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.09.078","article-title":"The impact of hydroxychloroquine treatment on pregnancy outcome in women with antiphospholipid antibodies","volume":"214","author":"Sciascia","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.medcli.2024.05.001_bib0375","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1177\/0961203319843343","article-title":"Hydroxychloroquine treatment during pregnancy in lupus patients is associated with lower risk of preeclampsia","volume":"28","author":"Seo","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.medcli.2024.05.001_bib0380","doi-asserted-by":"crossref","first-page":"102828","DOI":"10.1016\/j.autrev.2021.102828","article-title":"On the use of intravenous immunoglobulins for the treatment of the antiphospholipid syndrome \u2013 a systematic review and meta-analysis","volume":"20","author":"Lalmahomed","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.medcli.2024.05.001_bib0385","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1172\/JCI86957","article-title":"Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy","volume":"126","author":"Lefkou","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.medcli.2024.05.001_bib0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2021.05.018","article-title":"A randomized pilot clinical trial of pravastatin versus placebo in pregnant patients at high-risk of preeclampsia","volume":"225","author":"Costantine","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.medcli.2024.05.001_bib0395","doi-asserted-by":"crossref","first-page":"1021548","DOI":"10.3389\/fphar.2022.1021548","article-title":"Pravastatin and placental insufficiency associated disorders: a systematic review and meta-analysis","volume":"13","author":"Hirsch","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.medcli.2024.05.001_bib0400","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejogrb.2023.01.036","article-title":"Pravastatin for severe preeclampsia with growth restriction: Placental findings and infant follow-up","volume":"283","author":"Fruci","year":"2023","journal-title":"Eur J Obstet Gyn R B"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324002707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324002707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T23:51:37Z","timestamp":1726617097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775324002707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":40,"alternative-id":["S0025775324002707"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2024.05.001","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obstetric antiphospholipid syndrome","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2024.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}